Study Title | A randomized Phase III study of vincristine& dactinomycin& cyclophosphamide (VAC) alternating with vincristine and irinotecan (VI) versus VAC/VI plus temsirolimus (TEM) in patients with intermediate risk (IR) rhabdomyosarcoma (RMS) |
---|---|
Protocol ID | ARST1431 |
Disease (Sub Disease) | Rhabdomyosarcoma |
Diagnosis Stage | New diagnosis |
Location | NSW / QLD / WA / NZ |
Sponsor | National Cancer Institute (NCI) |
Links | https://clinicaltrials.gov/ct2/show/NCT02567435 |
Trial Status | Open |
Trial Open Date | 09/12/2016 |
Sites | The Children's Hospital at Westmead / John Hunter Children's Hospital / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Christchurch Hospital / Starship Hospital |
Study Type | Treatment |
Phase | Phase 3 |
Age Eligibility | under 40 years of age |
International registry ID's | NCT02567435 |